WIERENGA WENDELL sold CRNX
September 1, 2026 · Form 4 insider transaction
WIERENGA WENDELL sold 5,925 shares of Crinetics Pharmaceuticals Inc at $85.00 per share, a transaction worth $503.6K. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The transaction reported on this line reflects the cancellation in the Merger of restricted stock units of the Company (each, a "Company RSU"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. Immediately prior to the Effective Time, each Company RSU that was then outstanding but not vested became immediately vested in full. At the Effective Time, each outstanding Company RSU was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration, less any applicable tax withholding.